What is the clinical evidence from this study?

Study design: Observational. Population: Familial hypertrophic cardiomyopathy (n=132). Intervention: Genetic analysis of the beta-myosin heavy chain gene vs. Healthy controls. Primary outcome: Detection of beta-myosin heavy chain gene mutations.

December 1, 1992Journal of Clinical InvestigationOpen Access

Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy.

View Full Paper

Ask AI

Bookmark

Key result

A novel 2.4-kb deletion in the beta-myosin heavy chain gene was identified in a family with hypertrophic cardiomyopathy, though its definitive causal role remains uncertain due to variable penetrance.

Key Points

The aim is to identify novel mutations in the beta-myosin heavy chain gene associated with familial hypertrophic cardiomyopathy.
Identified mutations through Southern blots and PCR amplification of beta MHC gene segments.
Sequenced the amplified products to analyze mutations in the proband's DNA.
Assessed family inheritance patterns of the detected mutations.
A novel 2.4-kb nucleotide deletion in the beta MHC gene was found in the proband.
Three other family members inherited the deletion but remained asymptomatic as of ages 10, 32, and 33.
Clinical HCM was diagnosed in the proband at age 59, indicating late onset of the disease.

Study Design

Type

Observational (n=132)

Structured PICO

Population

A family with hypertrophic cardiomyopathy (proband age 67, diagnosed at 59) and 59 probands with familial hypertrophic cardiomyopathy, plus 73 unrelated normal individuals.

Intervention

Genetic analysis including Southern blot, PCR, cloning, and sequencing of the beta-myosin heavy chain (beta MHC) gene.

Outcome

Detection and characterization of mutations in the beta-myosin heavy chain gene.

The study identifies a novel 2.4-kb deletion in the beta-myosin heavy chain gene associated with late-onset familial hypertrophic cardiomyopathy.

Limitations

Small family size precludes linkage analysis to confirm a chromosome 14 disease locus.
Inability to detect a transcript from the mutant allele to conclusively prove the deletion mutation is responsible for the disease.
Clinical criteria alone may not be sensitive enough to identify all affected family members.
Variable penetrance and late onset of the disease complicate the interpretation of the mutation's causal role.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Does not support clinical adoption of this variant; leaves open its definitive causal role in familial HCM.

Cite This Study

Marian et al. (1992) conducted an observational in Familial hypertrophic cardiomyopathy (n=132). Genetic analysis of the beta-myosin heavy chain gene vs. Healthy controls was evaluated on Detection of beta-myosin heavy chain gene mutations. A novel 2.4-kb deletion in the beta-myosin heavy chain gene was identified in a family with hypertrophic cardiomyopathy, though its definitive causal role remains uncertain due to variable penetrance.

synapsesocial.com/papers/6a160d49ec4058fde8c5bdd7 https://doi.org/10.1172/jci116101

Topics

Hypertrophic cardiomyopathy

View Full Paper

Ask AI

Bookmark

Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy.

Key Points

Study Design

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Topics

Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy.

Key Points

Study Design

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Keep reading

Topics

Keep reading